These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 1755429

  • 21. [Transfer of injected sulbactam/cefoperazone into burn blister fluid].
    Aoyama H, Sugiyama H, Tada M, Okuda J, Izawa Y.
    Jpn J Antibiot; 1988 Sep; 41(9):1279-84. PubMed ID: 3241326
    [Abstract] [Full Text] [Related]

  • 22. [Experimental and clinical studies of sulbactam/cefoperazone in pediatric field].
    Nakashima T, Ueda S, Hayakawa F, Miyachi Y, Hakamada S, Kuno K.
    Jpn J Antibiot; 1984 Oct; 37(10):1846-58. PubMed ID: 6094864
    [Abstract] [Full Text] [Related]

  • 23. [Enhancement of susceptibility of sulbactam/cefoperazone-treated bacteria to phagocytes].
    Tanaka T, Iida-Tanaka K, Irino S.
    Jpn J Antibiot; 1991 Jul; 44(7):732-5. PubMed ID: 1886199
    [Abstract] [Full Text] [Related]

  • 24. [Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections].
    Nakamura A, Himi K, Matsumura C, Suzuki H, Kurosaki T, Sugaya N, Terashima I, Uehara S.
    Jpn J Antibiot; 1984 Oct; 37(10):1793-800. PubMed ID: 6094859
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Ito K, Kondo H, Hayasaki M, Noda K.
    Jpn J Antibiot; 1984 Nov; 37(11):2193-202. PubMed ID: 6098712
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [A case of acute bacterial prostatitis caused by gram positive cocci].
    Suzuki K, Horiba M.
    Hinyokika Kiyo; 1991 Dec; 37(12):1715-7. PubMed ID: 1785399
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
    Greenberg RN, Reilly PM, Weinandt WJ, Bollinger M, Kennedy DJ.
    Clin Ther; 1987 Dec; 10(1):52-6. PubMed ID: 3329965
    [Abstract] [Full Text] [Related]

  • 33. [Passage into the human milk and clinical evaluation of sulbactam/cefoperazone].
    Matsuda S, Kashiwagura T, Hirayama H.
    Jpn J Antibiot; 1985 Feb; 38(2):223-9. PubMed ID: 2989572
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical and bacteriological study of sparfloxacin on bacterial prostatitis].
    Suzuki K, Horiba M, Naide Y, Shinoda M, Hibi H.
    Hinyokika Kiyo; 1992 Jan; 38(1):121-8. PubMed ID: 1312292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.